F84.0 F84.1 F84.5
Conditions
Interventions
Group 1: Intervention Group (BASS-Teams Treatment Model): Adults with a confirmed diagnosis of autism spectrum disorder (ASD) receive access to the BASS-Teams treatment model for 12 months (the freque
Sponsors
Universitätsklinikum Hamburg-Eppendorf
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults with autism spectrum disorder (ASD). Inclusion criteria are: written documentation of a substantiated suspected diagnosis or confirmed diagnosis of autism spectrum disorder (e.g., ICD-10: F84.0, F84.1, F84.5), issued by a specialist physician in psychiatry and psychotherapy or a licensed psychological psychotherapist; place of residence within a maximum of 1 hour travel time (by public transport) from the respective regional BASS treatment team site; enrolment in a German statutory health insurance scheme; sufficient language proficiency (German).
Exclusion criteria
Exclusion criteria: Diagnosis of intellectual disability (z.B. ICD-10: F71, F72, F73); 2. diagnosis of an organic mental disorder (z. B. ICD-10: F00-F09).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Three hierarchically ordered primary endpoints: 1. Perceived barriers in healthcare: Self-report using the German version of the Barriers to Healthcare Checklist – Short Form (BHC-SF), assessed as a total sum score; evaluated at baseline and after 12 months (patients). 2. Mental health-related quality of life: Self-report using the Mental Component Summary of the Short-Form Health Survey (MCS SF-8); evaluated at baseline and after 12 months (patients). 3. Global level of functioning: Clinician-rated assessment using the Global Assessment of Functioning Scale (GAF); evaluated at baseline and after 12 months (patients). | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of Clinical Effectiveness: 1. Patient empowerment: Self-report using the Patient Enablement Questionnaire (PEN13) as a total sum score; assessed at baseline, after 6 months, and after 12 months (patients). 2. Depressive symptoms: Self-report using the Patient Health Questionnaire-9 (PHQ-9) as a total sum score; assessed at baseline, after 6 months, and after 12 months (patients). 3. Anxiety symptoms: Self-report using the Generalized Anxiety Disorder Scale 7 (GAD-7) as a total sum score; assessed at baseline, after 6 months, and after 12 months (patients). Health Economic Evaluation: 4. Cost-effectiveness ratio (incl. health-related quality of life): Self-report using the "Fragebogen zur Erhebung von Gesundheitsleistungen im Alter" (FIMA; Questionnaire for the Assessment of Healthcare Utilisation in Older Adults), the "Fragebogen zur Inanspruchnahme medizinischer und nicht medizinischer Versorgungsleistungen bei psychischen Erkrankungen" (FimPsy; Questionnaire on the Utilisation of Medical and Non-Medical Care Services in Mental Illness), and the EuroQol Group Questionnaire (EQ-5D-5L), with partial adaptation of items to the study and additional items developed in-house. Additionally, the routine documentation of health and social data by the cooperating statutory insurance company (Techniker Krankenkasse) will enable a more objective assessment of healthcare service utilization by the insured subsample of this company. This data will be analyzed at baseline and after six and 12 months. Implementation and Process Evaluation: 5. Perceived care barriers across multiple domains: Self-report using items developed in-house, based on the predecessor study "BarrierefreiASS" (e.g., characteristics of autism-specific care, availability of care structures, and access); assessed at baseline, after 6 and 12 months, or after 12 and 24 months, respectively (patients, clinicians, close relatives). 6. Implementation outcomes: Self-report using items develope | — |
Countries
Germany
Contacts
Public ContactJudith Peth
Universitätsklinikum Hamburg-Eppendorf
Outcome results
None listed